As filed with the Securities and Exchange Commission on January 6, 2005
Registration No. 333-82187
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE
AMENDMENT NO. 1
FORM S-8
REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933
OCULAR SCIENCES, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware | 94-2985696 | |
(State or Other Jurisdiction of Incorporation or organization) |
(I.R.S. Employer Identification No.) | |
6140 Stoneridge Mall Road, Suite 590
Pleasanton, CA 94588
(Address of Principal Executive Offices)
Ocular Sciences, Inc.
1997 Equity Incentive Plan, as amended
(Full Title of the Plans)
Carol R. Kaufman
Vice President and Secretary
TCC Acquisition Corp., successor by merger
6140 Stoneridge Mall Road, Suite 590
Pleasanton, CA 94588
(925) 460-3600
(Name, Address and Telephone Number of Agent for Service)
Copies to:
Erica H. Steinberger, Esq.
Latham & Watkins LLP
885 Third Avenue, Suite 1000
New York, NY 10022
(212) 906-1200
OCULAR SCIENCES, INC.
POST-EFFECTIVE AMENDMENT NO. 1 TO
REGISTRATION STATEMENT ON FORM S-8
REMOVAL OF SHARES FROM REGISTRATION
This Post-Effective Amendment No. 1 to Form S-8 Registration Statement relates to the Registration Statement on Form S-8 (File No. 333-82187), filed with the Securities and Exchange Commission on July 2, 1999, relating to 1,000,000 shares of common stock of Ocular Sciences, Inc. (Ocular) reserved for issuance under the Ocular Sciences, Inc. 1997 Equity Incentive Plan, as amended (the Plan).
On January 6, 2005, The Cooper Companies, Inc. (Cooper), TCC Acquisition Corp. (TCC) and Ocular completed the merger (the Merger) of Ocular with and into TCC pursuant to the terms and conditions of the Agreement and Plan of Merger, dated as of July 28, 2004, among such parties, as amended. As a result of the Merger, TCC is the surviving company, the successor by merger to Ocular and a direct wholly-owned subsidiary of Cooper. In connection with the Merger, shares of Ocular common stock outstanding under the Plan were converted into a combination of cash and shares of Cooper common stock, and the options exercisable for Ocular common stock outstanding under the Plan were converted into a combination of cash and shares of Cooper common stock.
This Post-Effective Amendment No. 1 to Form S-8 Registration Statement is being filed to remove from registration all securities previously registered under the Registration Statement that remain unsold.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Post-Effective Amendment No. 1 to its registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Pleasanton, State of California, on this 6th day of January, 2005.
TCC ACQUISITION CORP., successor by merger | ||
By: |
/s/ Carol R. Kaufman | |
Carol R. Kaufman | ||
Vice President and Secretary |
Pursuant to the requirements of the Securities Act, this Post-Effective Amendment No. 1 to the registration statement has been signed by the following persons in the capacities and on the dates indicated.
Signature |
Title |
Date | ||
Principal Executive Officer: |
||||
/s/ A. THOMAS BENDER |
President, Chief Executive Officer and Director |
January 6, 2005 | ||
A. Thomas Bender |
||||
Principal Financial and |
||||
Principal Accounting Officer: |
||||
/s/ ROBERT S. WEISS |
Vice President, Chief Financial Officer and Director |
January 6, 2005 | ||
Robert S. Weiss |
||||
Additional Directors: |
||||
/s/ CAROL R. KAUFMAN |
Vice President, Secretary and Director |
January 6, 2005 | ||
Carol R. Kaufman |
||||
/s/ GREGORY A. FRYLING |
Chief Operating Officer and Director |
January 6, 2005 | ||
Gregory A. Fryling |